2,286
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The first invasive Candida auris infection in Taiwan

ORCID Icon, , , , , , & show all
Pages 1867-1875 | Received 25 Apr 2022, Accepted 07 Jul 2022, Published online: 27 Jul 2022

References

  • Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41-44.
  • Centers for Disease Control and Prevention: General Information about Candida auris: Tracking Candida auris [cited 2021 Dec 27]. Available from: https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html. 2021.
  • Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021;9:807.
  • Osei Sekyere J. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen. 2018;7:e00578.
  • Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134–140.
  • Farmakiotis D, Kontoyiannis DP. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. Int J Antimicrob Agents. 2017;50:318–324.
  • Ostrowsky B, Adams E, et al. Candida auris isolates resistant to three classes of antifungal medications - New York, 2019. MMWR Morb Mortal Wkly Rep. 2020;69:6–9.
  • Du H, Bing J, Hu T, et al. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020;16:e1008921.
  • Chow NA, de Groot T, Badali H, et al. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019;25:1780–1781.
  • Mohd Tap R, Lim TC, Kamarudin NA, et al. A fatal case of Candida auris and Candida tropicalis candidemia in neutropenic patient. Mycopathologia. 2018;183:559–564.
  • Chayakulkeeree M, Ungulkraiwit P, Chongtrakool P, et al. The first case of Candida auris fungemia in Thailand. in: Gangneux JP, Lortholary O, Cornely OA et al. 9th trends in medical mycology held on 11-14 October 2019, nice, France, organized under the auspices of EORTC-IDG and ECMM. J Fungi. 2019;5:95.
  • Tan YE, Teo JQ, Rahman NBA, et al. Candida auris in Singapore: genomic epidemiology, antifungal drug resistance, and identification using the updated 8.01 VITEK®2 system. Int J Antimicrob Agents. 2019;54:709–715.
  • Lu PL, Liu WL, Lo HJ, et al. Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? J Formos Med Assoc. 2018;117:462–470.
  • Tang HJ, Lai CC, Lai FJ, et al. Emergence of multidrug-resistant Candida auris in Taiwan. Int J Antimicrob Agents. 2019;53:705–706.
  • Leaw SN, Chang HC, Sun HF, et al. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol. 2006;44:693–699.
  • Chowdhary A, Prakash A, Sharma C, et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother. 2018;73:891–899.
  • Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement M27-S4; CLSI: Wayne, PA, USA. 2012.
  • Centers for Disease Control and Prevention: Candida auris: Laboratorians and Health Professionals: Antifungal Susceptibility Testing. [cited 2021 Dec 27]. Available from: https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html. 2020.
  • de Groot T, Puts Y, Berrio I, et al. Development of Candida auris short tandem repeat typing and its application to a global collection of isolates. mBio. 2020;11:e02971–19.
  • Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017;72:1794–1801.
  • Rhodes J, Fisher MC. Global epidemiology of emerging Candida auris. Curr Opin Microbiol. 2019;52:84–89.
  • Chen J, Tian S, Han X, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20:827.
  • Desoubeaux G, Coste AT, Imbert C, et al. Overview about Candida auris: what's up 12 years after its first description? J Mycol Med. 2022;32:101248.
  • Tian S, Bing J, Chu Y, et al. Genomic epidemiology of Candida auris in a general hospital in Shenyang, China: a three-year surveillance study. Emerg Microbes Infect. 2021;10:1088–1096.
  • Bing J, Wang S, Xu H, et al. A case of Candida auris candidemia in Xiamen, China, and a comparative analysis of clinical isolates in China. Mycology. 2022;13:68–75.
  • Ding CH, Situ SF, Steven A, et al. The pitfall of utilizing a commercial biochemical yeast identification kit to detect Candida auris. Ann Clin Lab Sci. 2019;49:546–549.
  • Tan YE, Tan AL. Arrival of Candida auris fungus in Singapore: report of the first 3 cases. Ann Acad Med Singapore. 2018;47:260–262.
  • Sekizuka T, Iguchi S, Umeyama T, et al. Clade II Candida auris possess genomic structural variations related to an ancestral strain. PLoS One. 2019;14:e0223433.
  • Kwon YJ, Shin JH, Byun SA, et al. Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. J Clin Microbiol. 2019;57:e01624–18.
  • Tse H, Tsang AKL, Chu YW, et al. Draft genome sequences of 19 clinical isolates of Candida auris from Hong Kong. Microbiol Resour Announc. 2021;10:e00308–20.
  • Dutta S, Rahman MH, Hossain KS, et al. Detection of Candida auris and its antifungal susceptibility: first report from Bangladesh. IMC Journal of Medical Science. 2020;13:18–22.
  • Borman AM, Szekely A, Johnson EM. Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med Mycol. 2017;55:563–567.
  • de Almeida JN Jr., Francisco EC, Hagen F, et al. Emergence of Candida auris in Brazil in a COVID-19 intensive care unit. J Fungi (Basel). 2021;7:220.
  • Steinmann J, Schrauzer T, Kirchhoff L, et al. Two Candida auris cases in Germany with no recent contact to foreign healthcare-epidemiological and microbiological investigations. J Fungi (Basel). 2021;7:380.
  • Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31:e00029–17.
  • Xie O, Streitberg R, Hughes C, et al. Candida duobushaemulonii sepsis and Candida auris co-isolation following hospitalisation in Vietnam. Pathology. 2020;52:590–591.
  • Centers for Disease Control and Prevention: Candida auris: Laboratorians and Health Professionals [cited 2021 Dec 27]. Available from: https://www.cdc.gov/fungal/candida-auris/identification.html. 2020.
  • Mahmoudi S, Agha Kuchak Afshari S, Aghaei Gharehbolagh S, et al. Methods for identification of Candida auris, the yeast of global public health concern: A review. J Mycol Med. 2019;29:174–179.
  • Chindamporn A, Chakrabarti A, Li R, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative. Med Mycol. 2018;56:416–425.
  • Szekely A, Borman AM, Johnson EM. Candida auris isolates of the southern Asian and South African lineages exhibit different phenotypic and antifungal susceptibility profiles in vitro. J Clin Microbiol. 2019;57:e02055–18.
  • Chow NA, Munoz JF, Gade L, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio. 2020;11:e03364–19.
  • Maphanga TG, Naicker SD, Kwenda S, et al. In vitro antifungal resistance of Candida auris isolates from bloodstream infections, South Africa. Antimicrob Agents Chemother. 2021;65:e0051721.
  • Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect. 2018;7:93.
  • Shastri PS, Shankarnarayan SA, Oberoi J, et al. Candida auris candidaemia in an intensive care unit - prospective observational study to evaluate epidemiology, risk factors, and outcome. J Crit Care. 2020;57:42–48.
  • Sayeed MA, Farooqi J, Jabeen K, et al. Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan. BMC Infect Dis. 2019;19(384.
  • Chowdhary A, Tarai B, Singh A, et al. Multidrug-Resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020. Emerg Infect Dis. 2020;26:2694–2696.
  • Prestel C, Anderson E, Forsberg K, et al. Candida auris outbreak in a COVID-19 speciality care unit – Florida, July-August 2020. MMWR Morb Mortal Wkly Rep. 2021;70:56–57.
  • Villanueva-Lozano H, Trevino-Rangel RJ, Gonzalez GM, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect. 2021;27:813–816.
  • Magnasco L, Mikulska M, Giacobbe DR, et al. Spread of carbapenem-resistant gram-negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship? Microorganisms. 2021;9:95.